Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions

Untitled work

Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Sørlie, T., Perou, C., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M., van de Rijn, M., Jeffrey, S., et al. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.191367098 · Cited by 11,695 · see citing works

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works

Can the pharmaceutical industry reduce attrition rates?

Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167 · see citing works

Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling

Svetnik, V., Liaw, A. I., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,587 · see citing works

MoleculeNet: a benchmark for molecular machine learning

Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107 · see citing works

Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules

Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106 · see citing works

Mechanisms of Alternative Pre-Messenger RNA Splicing

Black, D. L. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161720 · Cited by 2,704 · see citing works

A Deep Learning Approach to Antibiotic Discovery

Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463 · see citing works

Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality

McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280 · see citing works

The blood–brain barrier: an overview

Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,276 · see citing works

A Century of Alzheimer's Disease

Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,106 · see citing works

A Landscape of Pharmacogenomic Interactions in Cancer

Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090 · see citing works

Neurobehavioural effects of developmental toxicity

Grandjean, P., & Landrigan, P. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70278-3 · Cited by 1,886 · see citing works

Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules.

Gómez‐Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera‐Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru‐Guzik, A. (2018) · Cambridge University Engineering Department Publications Database · doi:10.17863/cam.34134 · Cited by 1,813 · see citing works

Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures

Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744 · see citing works

Deep Reinforcement Learning That Matters

Henderson, P., Islam, R., Bachman, P., Pineau, J., Precup, D., & Meger, D. (2018) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v32i1.11694 · Cited by 1,685 · see citing works

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573 · see citing works

Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks

Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537 · see citing works

Multi-Omics Factor Analysis—a framework for unsupervised integration of multi-omics data sets

Argelaguet, R., Velten, B., Arnol, D., Dietrich, S., Zenz, T., Marioni, J. C., Buettner, F., Huber, W., & Stegle, O. (2018) · Molecular Systems Biology · doi:10.15252/msb.20178124 · Cited by 1,510 · see citing works

Modeling polypharmacy side effects with graph convolutional networks

Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501 · see citing works

Improved protein structure prediction using predicted interresidue orientations

Yang, J., Anishchenko, I., Park, H., Peng, Z., Ovchinnikov, S., & Baker, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914677117 · Cited by 1,421 · see citing works

Deep reinforcement learning for de novo drug design

Popova, M., Isayev, O., & Tropsha, A. (2018) · Science Advances · doi:10.1126/sciadv.aap7885 · Cited by 1,379 · see citing works

Transforming Auto-Encoders

Hinton, G. E., Krizhevsky, A., & Wang, S. D. (2011) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-21735-7_6 · Cited by 1,360 · see citing works

Molecular de-novo design through deep reinforcement learning

Olivecrona, M., Blaschke, T., Engkvist, O., & Chen, H. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0235-x · Cited by 1,358 · see citing works

Concepts and applications of molecular similarity

Johnson, M. A., & Maggiora, G. M. (1990) · Wiley eBooks · Cited by 1,322 · see citing works

Toxic Proteins in Neurodegenerative Disease

Taylor, J. P., Hardy, J., & Fischbeck, K. H. (2002) · Science · doi:10.1126/science.1067122 · Cited by 1,251 · see citing works

The human splicing code reveals new insights into the genetic determinants of disease

Xiong, H. Y., Alipanahi, B., Lee, L. J., Bretschneider, H., Merico, D., Yuen, R. K. C., Hua, Y., Gueroussov, S., Najafabadi, H. S., Hughes, T., et al. (2014) · Science · doi:10.1126/science.1254806 · Cited by 1,225 · see citing works

Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances

Lionta, E., Spyrou, G. M., Vassilatis, D. K., & Cournia, Z. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140929124445 · Cited by 1,220 · see citing works

Alzheimer’s disease: Clinical trials and drug development

Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · see citing works

Proteomic Analysis of the Cerebrospinal Fluid of Parkinson's Disease Patients Pre- and Post-Deep Brain Stimulation

Wang, E., Yao, H.-B., Chen, Y., Wang, G., Gao, W., Sun, Y., Guo, J., Hu, J., Jiang, C., & Hu, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350082 · Cited by 1,176 · see citing works

Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships

Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159 · see citing works

Prediction of drug–target interaction networks from the integration of chemical and genomic spaces

Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. I. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,148 · see citing works

DeepTox: toxicity prediction using deep learning

Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081 · see citing works

DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays

Singh, A., Shannon, C. P., Gautier, B., Rohart, F., Vacher, M. A., Tebbutt, S. J., & Cao, K. L. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty1054 · Cited by 1,076 · see citing works

Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery

Yang, X. Y., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,045 · see citing works

Artificial intelligence in drug development: Present status and future prospects

Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018 · see citing works

A machine learning approach to predicting protein–ligand binding affinity with applications to molecular docking

Ballester, P. J., & Mitchell, J. B. O. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq112 · Cited by 988 · see citing works

Artificial intelligence for mental health and mental illnesses: an overview

Graham, S., Depp, C., Lee, E. E., Nebeker, C., Tu, X., Kim, H.-C., & Jeste, D. V. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1094-0 · Cited by 970 · see citing works

Machine Learning Approaches for Clinical Psychology and Psychiatry

Dwyer, D. B., Falkai, P., & Koutsouleris, N. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045037 · Cited by 966 · see citing works

Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?

Reeve, A. K., Simcox, E. M., & Turnbull, D. M. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.004 · Cited by 961 · see citing works

Opportunities and challenges in phenotypic drug discovery: an industry perspective

Moffat, J. G., Vincent, F., Lee, J. A., Eder, J., & Prunotto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.111 · Cited by 939 · see citing works

Accurate De Novo Prediction of Protein Contact Map by Ultra-Deep Learning Model

Wang, S., Sun, S., Li, Z., Zhang, R., & Xu, J. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005324 · Cited by 931 · see citing works

Computation of Octanol−Water Partition Coefficients by Guiding an Additive Model with Knowledge

Cheng, T., Zhao, Y., Li, X., Fu, L., Xu, Y., Zhang, X., Li, Y., Wang, R., & Lai, L. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700257y · Cited by 897 · see citing works

PREDICT: a method for inferring novel drug indications with application to personalized medicine

Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 892 · see citing works

Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines

Geeleher, P., Cox, N. J., & Huang, R. S. (2014) · Genome biology · doi:10.1186/gb-2014-15-3-r47 · Cited by 889 · see citing works

Molecular fingerprint similarity search in virtual screening

Cereto‐Massagué, A., Ojeda, M. J., Valls, C., Mulero, M., Garcı́a-Vallvé, S., & Pujadas, G. (2014) · Methods · doi:10.1016/j.ymeth.2014.08.005 · Cited by 851 · see citing works

Similarity-based virtual screening using 2D fingerprints

Willett, P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.005 · Cited by 849 · see citing works

Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis

Shen, R., Olshen, A. B., & Ladanyi, M. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp543 · Cited by 849 · see citing works

Protein–Ligand Scoring with Convolutional Neural Networks

Ragoza, M., Hochuli, J. E., Idrobo, E., Sunseri, J., & Koes, D. R. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00740 · Cited by 835 · see citing works

Machine Learning for Precision Psychiatry: Opportunities and Challenges

Bzdok, D., & Meyer‐Lindenberg, A. (2017) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.11.007 · Cited by 833 · see citing works

Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease

Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820 · cited 1× · see citing works

Functional ultrasound imaging of the brain

Macé, É., Montaldo, G., Cohen, I., Baulac, M., Fink, M., & Tanter, M. (2011) · Nature Methods · doi:10.1038/nmeth.1641 · Cited by 757 · see citing works

Cross-trial prediction of treatment outcome in depression: a machine learning approach

Chekroud, A. M., Zotti, R. J., Shehzad, Z., Gueorguieva, R., Johnson, M. K., Trivedi, M. H., Cannon, T. D., Krystal, J. H., & Corlett, P. R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00471-x · Cited by 676 · see citing works

Drug discovery and development: Role of basic biological research

Mohs, R. C., & Greig, N. H. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.10.005 · Cited by 674 · see citing works

Development and evaluation of a deep learning model for protein–ligand binding affinity prediction

Stepniewska-Dziubinska, M. M., Zielenkiewicz, P., & Siedlecki, P. S. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty374 · Cited by 665 · see citing works

Deep learning improves prediction of drug–drug and drug–food interactions

Ryu, J. Y., Kim, H. U., & Lee, S. Y. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803294115 · Cited by 662 · see citing works

Advancing drug discovery via artificial intelligence

Chan, H. C. S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.06.004 · Cited by 654 · see citing works

DeepSynergy: predicting anti-cancer drug synergy with Deep Learning

Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 651 · see citing works

Graph Convolutional Policy Network for Goal-Directed Molecular Graph GenerationPreprint

You, J., Liu, B., Ying, R., Pande, V. S., & Leskovec, J. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1806.02473 · Cited by 644 · see citing works

Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data

Aliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00248 · Cited by 610 · see citing works

druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico

Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587 · see citing works

Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis

Shen, R., Olshen, A. B., & Ladanyi, M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp659 · Cited by 566 · see citing works

Deep Architectures and Deep Learning in Chemoinformatics: The Prediction of Aqueous Solubility for Drug-Like Molecules

Lusci, A., Pollastri, G., & Baldi, P. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400187y · Cited by 557 · see citing works

Joint and individual variation explained (JIVE) for integrated analysis of multiple data types

Lock, E. F., Hoadley, K. A., Marron, J. S., & Nobel, A. B. (2013) · The Annals of Applied Statistics · doi:10.1214/12-aoas597 · Cited by 554 · see citing works

Retrosynthetic Reaction Prediction Using Neural Sequence-to-Sequence Models

Liu, B., Ramsundar, B., Kawthekar, P., Shi, J., Gomes, J., Luu Nguyen, Q., Ho, S., Sloane, J., Wender, P., & Pande, V. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00303 · Cited by 536 · see citing works

deepDR: a network-based deep learning approach toin silicodrug repositioning

Zeng, X., Zhu, S., Liu, X., Zhou, Y., Nussinov, R., & Cheng, F. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz418 · Cited by 532 · see citing works

Generative Recurrent Networks for De Novo Drug Design

Gupta, A., Müller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2017) · Molecular Informatics · doi:10.1002/minf.201700111 · Cited by 474 · see citing works

Convolutional embedding of attributed molecular graphs for physical property prediction

Coley, C. W., Barzilay, R., Green, W. H., Jaakkola, T. S., & Jensen, K. F. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00601 · Cited by 470 · see citing works

Deep learning of the tissue-regulated splicing code

Leung, M. K. K., Xiong, H. Y., Lee, L. J., & Frey, B. J. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu277 · Cited by 459 · see citing works

MolGAN: An implicit generative model for small molecular graphs

De Cao, N., & Kipf, T. (2018) · arXiv · doi:10.48550/arxiv.1805.11973 · Cited by 442 · see citing works

De novo generation of hit-like molecules from gene expression signatures using artificial intelligence

Méndez‐Lucio, O., Baillif, B., Clevert, D.-A., Rouquié, D., & Wichard, J. (2020) · Nature Communications · doi:10.1038/s41467-019-13807-w · Cited by 422 · see citing works

Molecular generative model based on conditional variational autoencoder for de novo molecular design

Lim, J., Ryu, S., Kim, J. W., & Kim, W. Y. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0286-7 · Cited by 421 · see citing works

MOLI: multi-omics late integration with deep neural networks for drug response prediction

Sharifi-Noghabi, H., Zolotareva, O., Collins, C. C., & Ester, M. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz318 · Cited by 421 · see citing works

ChemDes: an integrated web-based platform for molecular descriptor and fingerprint computation

Dong, J. N., Cao, D., Miao, H., Shao, L., Deng, B., Yun, Y., Wang, N., Lü, A., Zeng, W., & Chen, A. F. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0109-z · Cited by 407 · see citing works

Boosting docking-based virtual screening with deep learning.

Pereira, J. C., Caffarena, E. R., & dos Santos, C. N. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00355 · Cited by 395 · see citing works

Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces

Xia, Z., Wu, L., Zhou, X., & Wong, S. T. C. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-s2-s6 · Cited by 394 · see citing works

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

Abdi, F. A., Quinn, J. F., Jankovic, J. J., McIntosh, M. W., Leverenz, J. B., Peskind, E. R., Nixon, R., Nutt, J. G., Chung, K., Zabetian, C. P., et al. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9309 · Cited by 385 · see citing works

Prediction ofn-Octanol/Water Partition Coefficients from PHYSPROP Database Using Artificial Neural Networks and E-State Indices

Tetko, I. V., Tanchuk, V. Y., & Villa, A. E. P. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010368v · Cited by 382 · see citing works

Reinforced Adversarial Neural Computer for de Novo Molecular Design

Lane, E., Asadulaev, A., Ivanenkov, Y. A., Aladinskiy, V., Sánchez-Lengeling, B., Aspuru‐Guzik, A., & Zhavoronkov, A. A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00690 · Cited by 381 · see citing works

NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug–target interactions

Wan, F., Hong, L., Xiao, A., Jiang, T., & Zeng, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty543 · Cited by 381 · see citing works

Regularized Generalized Canonical Correlation Analysis

Tenenhaus, A., & Tenenhaus, M. (2011) · Psychometrika · doi:10.1007/s11336-011-9206-8 · Cited by 367 · see citing works

Machine‐learning scoring functions to improve structure‐based binding affinity prediction and virtual screening

Ain, Q. U., Aleksandrova, A., Roessler, F. D., & Ballester, P. J. (2015) · WIREs Computational Molecular Science · doi:10.1002/wcms.1225 · Cited by 357 · see citing works

Use of Artificial Intelligence in the Design of Small Peptide Antibiotics Effective against a Broad Spectrum of Highly Antibiotic-Resistant Superbugs

Cherkasov, A. R., Hilpert, K., Jenssen, H., Fjell, C. D., Waldbrook, M., Mullaly, S. C., Volkmer, R., & Hancock, R. E. W. (2008) · ACS Chemical Biology · doi:10.1021/cb800240j · Cited by 356 · see citing works

Classification of Kinase Inhibitors Using a Bayesian Model

Xia, X., Maliski, E. G., Gallant, P., & Rogers, D. O. W. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303195 · Cited by 352 · see citing works

Estimation of ADME Properties with Substructure Pattern Recognition

Shen, J., Cheng, F., Xu, Y., Li, W., & Tang, Y. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100104j · Cited by 351 · see citing works

The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology

Kadurin, A., Aliper, A., Kazennov, A., Mamoshina, P., Vanhaelen, Q., Khrabrov, K., & Zhavoronkov, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14073 · Cited by 350 · see citing works

Drug repositioning: a machine-learning approach through data integration

Napolitano, F., Zhao, Y., Moreira, V. M., Tagliaferri, R., Kere, J., D’Amato, M., & Greco, D. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-30 · Cited by 349 · see citing works

Recent Advances in Ligand-Based Drug Design: Relevance and Utility of the Conformationally Sampled Pharmacophore Approach

Acharya, C., Coop, A., Polli, J. E., & MacKerell, A. D. (2010) · Current Computer - Aided Drug Design · doi:10.2174/157340911793743547 · Cited by 343 · see citing works

Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases

Nidhi, N., Glick, M., Davies, J. W., & Jenkins, J. L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060003g · Cited by 340 · see citing works

A Bayesian Approach to in Silico Blood-Brain Barrier Penetration Modeling

Martins, I. F. D. S., Teixeira, A. L., Pinheiro, L., & Falcão, A. O. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300124c · Cited by 336 · see citing works

Target discovery

Lindsay, M. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1202 · Cited by 333 · see citing works

TopologyNet: Topology based deep convolutional and multi-task neural networks for biomolecular property predictions

Cang, Z., & Wei, G.-W. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005690 · Cited by 330 · see citing works

Current Trends in Ligand-Based Virtual Screening: Molecular Representations, Data Mining Methods, New Application Areas, and Performance Evaluation

Geppert, H., Vogt, M., & Bajorath, J. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci900419k · Cited by 328 · see citing works

Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors

Xuan, P., Han, K., Guo, M., Guo, Y., Li, J., Ding, J., Liu, Y., Dai, Q., Li, J., Teng, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070204 · Cited by 325 · see citing works

Properties and identification of human protein drug targets

Bakheet, T. M., & Doig, A. J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp002 · Cited by 323 · see citing works

The $2.6 Billion Pill — Methodologic and Policy Considerations

Avorn, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500848 · Cited by 322 · see citing works

Constrained Graph Variational Autoencoders for Molecule DesignPreprint

Liu, Q., Allamanis, M., Brockschmidt, M., & Gaunt, A. L. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1805.09076 · Cited by 321 · see citing works

AlphaFold at CASP13

AlQuraishi, M. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz422 · Cited by 315 · see citing works

An electroencephalographic signature predicts antidepressant response in major depression

Wu, W., Zhang, Y., Jiang, J., Lucas, M. V., Fonzo, G. A., Rolle, C. E., Cooper, C., Chin-Fatt, C., Krepel, N., Cornelssen, C. A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0397-3 · Cited by 302 · see citing works

An Introduction to Terminology and Methodology of Chemical Synergy—Perspectives from Across Disciplines

Roell, K. R., Reif, D. M., & Motsinger‐Reif, A. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00158 · Cited by 299 · see citing works

Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning

Fjell, C. D., Jenssen, H., Hilpert, K., Cheung, W., Panté, N., Hancock, R. E. W., & Cherkasov, A. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8015365 · Cited by 297 · see citing works

Drug—drug interaction through molecular structure similarity analysis

Vilar, S., Harpaz, R., Uriarte, E., Santana, L., Rabadán, R., & Friedman, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-000935 · Cited by 289 · see citing works

Deep learning methods in protein structure prediction

Torrisi, M., Pollastri, G., & Le, Q. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.011 · Cited by 289 · see citing works

On the nature of cavities on protein surfaces: Application to the identification of drug‐binding sites

Nayal, M., & Honig, B. H. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20897 · Cited by 285 · see citing works

In Silico Prediction of Chemical Toxicity for Drug Design Using Machine Learning Methods and Structural Alerts

Yang, H., Sun, L., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00030 · Cited by 282 · see citing works

An overview of molecular fingerprint similarity search in virtual screening

Muegge, I., & Mukherjee, P. K. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1117070 · Cited by 278 · see citing works

Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery

Polykovskiy, D., Zhebrak, A., Vetrov, D., Ivanenkov, Y., Aladinskiy, V., Mamoshina, P., Bozdaganyan, M., Aliper, A., Zhavoronkov, A., & Kadurin, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00839 · Cited by 278 · see citing works

Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach

Chekroud, A. M., Gueorguieva, R., Krumholz, H. M., Trivedi, M. H., Krystal, J. H., & McCarthy, G. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0025 · Cited by 276 · see citing works

Mol-CycleGAN: a generative model for molecular optimization

Maziarka, Ł., Pocha, A., Kaczmarczyk, J., Rataj, K., Danel, T., & Warchoł, M. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-019-0404-1 · Cited by 275 · see citing works

Aggression in autism spectrum disorder: presentation and treatment options

Fitzpatrick, S. E., Srivorakiat, L., Wink, L. K., Pedapati, E. V., & Erickson, C. A. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s84585 · Cited by 273 · see citing works

A Bayesian machine learning approach for drug target identification using diverse data types

Madhukar, N. S., Khade, P. K., Huang, L., Gayvert, K. M., Galletti, G., Stogniew, M., Allen, J. E., Giannakakou, P., & Elemento, O. (2019) · Nature Communications · doi:10.1038/s41467-019-12928-6 · Cited by 267 · see citing works

Extraction of relations between genes and diseases from text and large-scale data analysis: implications for translational research

Bravo, Á., Piñero, J., Queralt-Rosiñach, N., Rautschka, M., & Furlong, L. I. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0472-9 · Cited by 266 · see citing works

Quo Vadis, Virtual Screening? A Comprehensive Survey of Prospective Applications

Ripphausen, P., Nisius, B., Peltason, L., & Bajorath, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101020z · Cited by 263 · see citing works

Assessing the impact of generative AI on medicinal chemistry

Walters, W. P., & Murcko, M. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0418-2 · Cited by 262 · see citing works

Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model

Torrent, M., Andreu, D., Nogués, M. V., & Boix, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016968 · Cited by 261 · see citing works

Revolution Stalled

Hyman, S. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003142 · Cited by 260 · see citing works

NNScore: A Neural-Network-Based Scoring Function for the Characterization of Protein−Ligand Complexes

Durrant, J. D., & McCammon, J. A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100244v · Cited by 258 · see citing works

Improving AutoDock Vina using random forest: the growing accuracy of binding affinity prediction by the effective exploitation of larger data sets

Li, H., Leung, K., Wong, M., & Ballester, P. J. (2015) · Molecular Informatics · doi:10.1002/minf.201400132 · Cited by 252 · see citing works

Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Qosa, H., Miller, D. S., Pasinelli, P., & Trotti, D. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.005 · Cited by 249 · see citing works

Structure-based virtual screening of chemical libraries for drug discovery

Ghosh, S., Nie, A., An, J., & Huang, Z. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.04.002 · Cited by 246 · see citing works

Comprehensive ensemble in QSAR prediction for drug discovery

Kwon, S., Bae, H., Jo, J., & Yoon, S. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3135-4 · Cited by 243 · see citing works

Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis

Struble, T. J., Alvarez, J. C., Brown, S. P., Chytil, M., Cisar, J. S., DesJarlais, R. L., Engkvist, O., Frank, S. A., Greve, D. R., Griffin, D. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02120 · Cited by 243 · see citing works

Molecular similarity and diversity in chemoinformatics: From theory to applications

Maldonado, A. G., Doucet, J. P., Petitjean, M., & Fan, B. (2006) · Molecular Diversity · doi:10.1007/s11030-006-8697-1 · Cited by 239 · see citing works

What makes a good drug target?

Gashaw, I., Ellinghaus, P., Sommer, A., & Asadullah, K. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.007 · Cited by 238 · see citing works

Demystifying Multitask Deep Neural Networks for Quantitative Structure–Activity Relationships

Xu, Y., Ma, J., Liaw, A., Sheridan, R. P., & Svetnik, V. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00087 · Cited by 238 · see citing works

A multiple kernel learning algorithm for drug-target interaction prediction

do Nascimento, A. C. A., Prudêncio, R. B. C., & Costa, I. G. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-0890-3 · Cited by 235 · see citing works

In silicoADME-Tox modeling: progress and prospects

Alqahtani, S. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1389897 · Cited by 232 · see citing works

DeepSMILES: An Adaptation of SMILES for Use in Machine-Learning of Chemical StructuresPreprint

O’Boyle, N. M., & Dalke, A. (2018) · ChemRxiv · doi:10.26434/chemrxiv.7097960.v1 · Cited by 231 · see citing works

A Machine Learning-Based Method To Improve Docking Scoring Functions and Its Application to Drug Repurposing

Kinnings, S., Liu, N., Tonge, P. J., Jackson, R. M., Xie, L., & Bourne, P. E. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100369f · Cited by 229 · see citing works

Tox21Challenge to Build Predictive Models of Nuclear Receptor and Stress Response Pathways as Mediated by Exposure to Environmental Chemicals and Drugs

Huang, R., Xia, M., Nguyễn, Ð.-T., Zhao, T., Sakamuru, S., Zhao, J., Shahane, S. A., Rossoshek, A., & Simeonov, A. M. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00085 · Cited by 229 · see citing works

Shape-Based Generative Modeling for de Novo Drug Design

Skalic, M., Jiménez, J., Sabbadin, D., & De Fabritiis, G. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00706 · Cited by 229 · see citing works

Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets

Wenzel, J., Matter, H., & Schmidt, F. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00785 · Cited by 227 · see citing works

Learning Molecular Representations for Medicinal Chemistry

Chuang, K. V., Gunsalus, L. M., & Keiser, M. J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00385 · Cited by 227 · see citing works

Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus

Reker, D., Rodrigues, T., Schneider, P., & Schneider, G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320001111 · Cited by 226 · see citing works

Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer

Xu, J., Li, C., Lv, J.-Y., Li, Y.-S., Xiao, Y., Shao, T., Huo, X., Li, X., Zou, Y., Han, Q., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0055 · Cited by 226 · see citing works

DeepCC: a novel deep learning-based framework for cancer molecular subtype classification

Gao, F., Wang, W., Tan, M., Zhu, L., Zhang, Y., Fessler, E., Vermeulen, L., & Wang, X. (2019) · Oncogenesis · doi:10.1038/s41389-019-0157-8 · Cited by 226 · see citing works

Toward the Autism Motor Signature: Gesture patterns during smart tablet gameplay identify children with autism

Anzulewicz, A., Sobota, K., & Delafield‐Butt, J. T. (2016) · Scientific Reports · doi:10.1038/srep31107 · Cited by 220 · see citing works

Combining Drug and Gene Similarity Measures for Drug-Target Elucidation

Perlman, L., Gottlieb, A., Atias, N., Ruppin, E., & Sharan, R. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0213 · Cited by 218 · see citing works

Detecting Neuroimaging Biomarkers for Schizophrenia: A Meta-Analysis of Multivariate Pattern Recognition Studies

Kambeitz, J. P., Kambeitz‐Ilankovic, L., Leucht, S., Wood, S. J., Davatzikos, C. A., Malchow, B., Falkai, P., & Koutsouleris, N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.22 · Cited by 217 · see citing works

Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach

Koutsouleris, N., Kahn, R. S., Chekroud, A. M., Leucht, S., Falkai, P., Wobrock, T., Derks, E. M., Fleischhacker, W., & Hasan, A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30171-7 · Cited by 217 · see citing works

Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades

Göller, A. H., Kuhnke, L., Montanari, F., Bonin, A., Schneckener, S., ter Laak, A., Wichard, J., Lobell, M., & Hillisch, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.001 · Cited by 215 · see citing works

Gaussian Processes: A Method for Automatic QSAR Modeling of ADME Properties

Obrezanova, O., Cśanyi, G., Gola, J. M. R., & Segall, M. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci7000633 · Cited by 214 · see citing works

Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1

Geier, E. G., Schlessinger, A., Fan, H., Gable, J. E., Irwin, J. J., Šali, A., & Giacomini, K. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218165110 · Cited by 212 · see citing works

Machine learning models for drug–target interactions: current knowledge and future directions

D’Souza, S., Prema, K. V., & Balaji, S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.003 · Cited by 209 · see citing works

Deep‐learning contact‐map guided protein structure prediction in CASP13

Zheng, W., Li, Y., Zhang, C., Pearce, R., Mortuza, S. M., & Zhang, Y. (2019) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.25792 · Cited by 208 · see citing works

Putting the Patient Back Together — Social Medicine, Network Medicine, and the Limits of Reductionism

Greene, J. A., & Loscalzo, J. (2017) · New England Journal of Medicine · doi:10.1056/nejmms1706744 · Cited by 206 · see citing works

Machine Learning in Virtual Screening

Melville, J. L., Burke, E. K., & Hirst, J. D. (2009) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620709788167980 · Cited by 203 · see citing works

In Silico Prediction of Blood–Brain Barrier Permeability of Compounds by Machine Learning and Resampling Methods

Wang, Z., Yang, H., Wu, Z., Wang, T., Li, W., Tang, Y., & Liu, G. (2018) · ChemMedChem · doi:10.1002/cmdc.201800533 · Cited by 203 · see citing works

Deep learning-based multi-omics data integration reveals two prognostic subtypes in high-risk neuroblastoma

Zhang, L., Lv, C., Jin, Y., Cheng, G., Fu, Y., Yuan, D., Tao, Y., Guo, Y., Ni, X., & Shi, T. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00477 · Cited by 203 · see citing works

Improvement in ADMET Prediction with Multitask Deep Featurization

Feinberg, E. N., Joshi, E., Pande, V. S., & Cheng, A. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02187 · Cited by 203 · see citing works

QSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic Compounds

Zhang, L., Zhu, H., Oprea, T. I., Golbraikh, A., & Tropsha, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9609-0 · Cited by 201 · see citing works

In Silico Prediction of Physicochemical Properties of Environmental Chemicals Using Molecular Fingerprints and Machine Learning

Zang, Q., Mansouri, K., Williams, A. J., Judson, R., Allen, D., Casey, W., & Kleinstreuer, N. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00625 · Cited by 199 · see citing works

Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer

Malyutina, A., Majumder, M. M., Wang, W., Pessia, A., Heckman, C. A., & Tang, J. P. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006752 · Cited by 199 · see citing works

Optimizing distributions over molecular space. An Objective-Reinforced Generative Adversarial Network for Inverse-design Chemistry (ORGANIC)Preprint

Sánchez-Lengeling, B., Outeiral, C., Guimaraes, G. L., & Aspuru‐Guzik, A. (2017) · ChemRxiv · doi:10.26434/chemrxiv.5309668.v3 · Cited by 195 · see citing works

An in silico platform for predicting, screening and designing of antihypertensive peptides

Kumar, R., Chaudhary, K., Chauhan, J. S., Nagpal, G., Kumar, R., Sharma, M., & Raghava, G. P. S. (2015) · Scientific Reports · doi:10.1038/srep12512 · Cited by 193 · see citing works

Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics

Ding, M. Q., Chen, L., Cooper, G. F., Young, J. D., & Lu, X. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0378 · Cited by 191 · see citing works

ID-Score: A New Empirical Scoring Function Based on a Comprehensive Set of Descriptors Related to Protein–Ligand Interactions

Li, G., Yang, L., Wang, W., Li, L., & Yang, S. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300493w · Cited by 181 · see citing works

Regularized Generalized Canonical Correlation Analysis: A Framework for Sequential Multiblock Component Methods

Tenenhaus, M., Tenenhaus, A., & Groenen, P. J. F. (2017) · Psychometrika · doi:10.1007/s11336-017-9573-x · Cited by 177 · see citing works

Applying machine learning techniques for ADME-Tox prediction: a review

Maltarollo, V. G., Gertrudes, J. C., Oliveira, P. R., & Honorio, K. M. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.980814 · Cited by 176 · see citing works

SFCscore RF : A Random Forest-Based Scoring Function for Improved Affinity Prediction of Protein–Ligand Complexes

Zilian, D., & Sotriffer, C. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400120b · Cited by 174 · see citing works

Dr.VAE: improving drug response prediction via modeling of drug perturbation effects

Rampášek, L., Hidru, D., Smirnov, P., Haibe‐Kains, B., & Goldenberg, A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz158 · Cited by 174 · see citing works

Activity, assay and target data curation and quality in the ChEMBL database

Papadatos, G., Gaulton, A., Hersey, A., & Overington, J. P. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9860-5 · Cited by 169 · see citing works

A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening

Jeon, J., Nim, S., Teyra, J., Datti, A., Wrana, J. L., Sidhu, S. S., Moffat, J., & Kim, P. M. (2014) · Genome Medicine · doi:10.1186/s13073-014-0057-7 · Cited by 169 · see citing works

Prediction of drug combination effects with a minimal set of experiments

Ianevski, A., Giri, A. K., Gautam, P., Kononov, A., Potdar, S., Saarela, J., Wennerberg, K., & Aittokallio, T. A. (2019) · Nature Machine Intelligence · doi:10.1038/s42256-019-0122-4 · Cited by 169 · see citing works

Comparison of the Predictive Performance and Interpretability of Random Forest and Linear Models on Benchmark Data Sets

Marchese Robinson, R. L., Palczewska, A., Palczewski, J., & Kidley, N. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00753 · Cited by 167 · see citing works

Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data

Wang, Y., Chen, S., Deng, N.-Y., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078518 · Cited by 164 · see citing works

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Bain, E., Shafner, L., Walling, D. P., Othman, A. A., Chuang‐Stein, C., Hinkle, J. E., & Hanina, A. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.7030 · Cited by 163 · see citing works

Predicting CNS Permeability of Drug Molecules: Comparison of Neural Network and Support Vector Machine Algorithms

Doniger, S. W., Hofmann, T. F., & Yeh, J. I. (2002) · Journal of Computational Biology · doi:10.1089/10665270260518317 · Cited by 161 · see citing works

DeepDSC: A Deep Learning Method to Predict Drug Sensitivity of Cancer Cell Lines

Li, M., Wang, Y., Zheng, R., Shi, X. M., Li, Y., Wu, F., & Wang, J. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2919581 · Cited by 159 · see citing works

Evaluating the molecule-based prediction of clinical drug responses in cancer

Ding, Z., Zu, S., & Gu, J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw344 · Cited by 155 · see citing works

Silymarin Ameliorates Acrylamide-Induced Hyperlipidemic Cardiomyopathy in Male Rats

Abdel-Moneim, A. M., Elsawy, H., Alzahrani, A. M., Ali, A. M., & Mahmoud, O. (2019) · BioMed Research International · doi:10.1155/2019/4825075 · Cited by 154 · see citing works

Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data

Sidorov, P., Naulaerts, S., Ariey-Bonnet, J., Pasquier, E., & Ballester, P. J. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00509 · Cited by 151 · see citing works

Prediction of passive blood–brain partitioning: Straightforward and effective classification models based on in silico derived physicochemical descriptors

Vilar, S., Chakrabarti, M., & Costanzi, S. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.03.010 · Cited by 149 · see citing works

What has virtual screening ever done for drug discovery?

Clark, D. E. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.8.841 · Cited by 148 · see citing works

Optimizing distributions over molecular space. An Objective-Reinforced Generative Adversarial Network for Inverse-design Chemistry (ORGANIC)Preprint

Sánchez-Lengeling, B., Outeiral, C., Guimaraes, G. L., & Aspuru‐Guzik, A. (2017) · ChemRxiv · doi:10.26434/chemrxiv.5309668.v2 · Cited by 148 · see citing works

Deep Learning and Virtual Drug Screening

Carpenter, K. A., Cohen, D. S., Jarrell, J. T., & Huang, X. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0314 · Cited by 145 · see citing works

Predicting Penetration Across the Blood-Brain Barrier from Simple Descriptors and Fragmentation Schemes

Zhao, Y. H., Abraham, M. H., Ibrahim, A., Fish, P. V., Cole, S. M., Lewis, M. L., de Groot, M. J., & Reynolds, D. P. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600312d · Cited by 141 · see citing works

Regulation of ABC Transporters Blood–Brain Barrier

Miller, D. S. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.10.002 · Cited by 141 · see citing works

Predicting functional effects of missense variants in voltage-gated sodium and calcium channels

Heyne, H. O., Baez-Nieto, D., Iqbal, S., Palmer, D. S., Brunklaus, A., May, P., Collaborative, E., Johannesen, K. M., Lauxmann, S., Lemke, J. R., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay6848 · Cited by 140 · see citing works

Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions

Myint, K.-Z., Wang, L., Tong, Q., & Xie, X.-Q. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300237z · Cited by 139 · see citing works

DrugE-Rank: improving drug–target interaction prediction of new candidate drugs or targets by ensemble learning to rank

Yuan, Q., Gao, J., Wu, D., Zhang, S., Mamitsuka, H., & Zhu, S. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw244 · Cited by 138 · see citing works

DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies

Han, Y., Yang, J., Qian, X., Cheng, W., Liu, S., Hua, X., Zhou, L., Yang, Y., Wu, Q., Liu, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz096 · Cited by 137 · see citing works

DigSee: disease gene search engine with evidence sentences (version cancer)

Kim, J.-K., So, S., Lee, H., Park, J. C., Kim, J., & Lee, H. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt531 · Cited by 136 · see citing works

Tuning artificial intelligence on the de novo design of natural-product-inspired retinoid X receptor modulators

Merk, D., Grisoni, F., Friedrich, L., & Schneider, G. (2018) · Communications Chemistry · doi:10.1038/s42004-018-0068-1 · Cited by 136 · see citing works

Revealing the macromolecular targets of complex natural products

Reker, D., Perna, A. M., Rodrigues, T., Schneider, P., Reutlinger, M., Mönch, B., Koeberle, A., Lamers, C., Gabler, M., Steinmetz, H., et al. (2014) · Nature Chemistry · doi:10.1038/nchem.2095 · Cited by 135 · see citing works

Machine Learning Methods for Protein Structure Prediction

Cheng, J. J., Tegge, A. N., & Baldi, P. (2008) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2008.2008239 · Cited by 134 · see citing works

A Simple Representation of Three-Dimensional Molecular Structure

Axen, S. D., Huang, X., Cáceres, E. L., Gendelev, L., Roth, B. L., & Keiser, M. J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00696 · Cited by 133 · see citing works

In silico prediction of novel therapeutic targets using gene–disease association data

Ferrero, E., Dunham, I., & Sanséau, P. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1285-6 · Cited by 132 · see citing works

In Silico Prediction of Blood Brain Barrier Permeability: An Artificial Neural Network Model

Garg, P., & Verma, J. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050303i · Cited by 131 · see citing works

Determining druggability

Owens, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2275 · Cited by 130 · see citing works

Predictions of the ADMET Properties of Candidate Drug Molecules Utilizing Different QSAR/QSPR Modelling Approaches

Khan, M. T. H. (2010) · Current Drug Metabolism · doi:10.2174/138920010791514306 · Cited by 127 · see citing works

Application of ALOGPS 2.1 to Predict log D Distribution Coefficient for Pfizer Proprietary Compounds

Tetko, I. V., & Poda, G. I. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049509l · Cited by 126 · see citing works

istar: A Web Platform for Large-Scale Protein-Ligand Docking

Li, H., Leung, K., Ballester, P. J., & Wong, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085678 · Cited by 126 · see citing works

CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer

Wong, W. C., Kim, D., Carter, H. K., Diekhans, M., Ryan, M., & Karchin, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr357 · Cited by 125 · see citing works

Quantitative structure–activity relationship: promising advances in drug discovery platforms

Wang, T., Wu, M., Lin, J., & Yang, L.-R. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1083006 · Cited by 124 · see citing works

2016 FDA drug approvals

Mullard, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.14 · Cited by 121 · see citing works

CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features

Mao, Y., Chen, H., Liang, H., Meric‐Bernstam, F., Mills, G. B., & Chen, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077945 · Cited by 120 · see citing works

A Semi-Supervised Method for Drug-Target Interaction Prediction with Consistency in Networks

Chen, H., & Zhang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062975 · Cited by 120 · see citing works

iDTI-ESBoost: Identification of Drug Target Interaction Using Evolutionary and Structural Features with Boosting

Rayhan, F., Ahmed, S., Shatabda, S., Farid, D. M., Mousavian, Z., Dehzangi, A., & Rahman, M. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-18025-2 · Cited by 120 · see citing works

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473 · see citing works

Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design

Vora, L. K., Gholap, A. D., Jetha, K. L., Singh, T. R. R., Solanki, H. K., & Chavda, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071916 · Cited by 1,152 · see citing works

The role of AI in drug discovery: challenges, opportunities, and strategies

Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690 · see citing works

Using artificial intelligence in academic writing and research: An essential productivity tool

Khalifa, M., & Albadawy, M. (2024) · Computer Methods and Programs in Biomedicine Update · doi:10.1016/j.cmpbup.2024.100145 · Cited by 580 · see citing works

AI-Driven Drug Discovery: A Comprehensive Review

Ferreira, F. J. N., & Carneiro, A. S. (2025) · ACS Omega · doi:10.1021/acsomega.5c00549 · Cited by 202 · see citing works

Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries

Selvaraj, C., Chandra, I., & Singh, S. K. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10326-z · Cited by 206 · see citing works

Generative machine learning for de novo drug discovery: A systematic review

Martinelli, D. D. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105403 · Cited by 177 · see citing works

Tribulations and future opportunities for artificial intelligence in precision medicine

Carini, C., & Seyhan, A. A. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05067-0 · Cited by 175 · see citing works

Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance

Huanbutta, K., Burapapadh, K., Kraisit, P., Sriamornsak, P., Ganokratanaa, T., Suwanpitak, K., & Sangnim, T. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106938 · Cited by 185 · see citing works

Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery

Tripathi, M. K., Nath, A., Singh, T. P., Ethayathulla, A. S., & Kaur, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10256-w · Cited by 146 · see citing works

A CRITICAL REVIEW OF AI-DRIVEN STRATEGIES FOR ENTREPRENEURIAL SUCCESS

Usman, F. O., Eyo-Udo, N. L., Etukudoh, E. A., Odonkor, B., Ibeh, C. V., & Adegbola, A. E. (2024) · International Journal of Management & Entrepreneurship Research · doi:10.51594/ijmer.v6i1.748 · Cited by 131 · see citing works

Multimodal AI in Biomedicine: Pioneering the Future of Biomaterials, Diagnostics, and Personalized Healthcare

Parvin, N., Joo, S., Jung, J. H., & Mandal, T. K. (2025) · Nanomaterials · doi:10.3390/nano15120895 · Cited by 130 · see citing works

Artificial intelligence and neuroscience: transformative synergies in brain research and clinical applications

Onciul, R., Tataru, C.-I., Dumitru, A. V., Crivoi, C., Serban, M., Covache-Busuioc, R.-A., Radoi, M. P., & Toader, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020550 · Cited by 113 · see citing works

AI empowering traditional Chinese medicine?

Song, Z., Chen, G., & Chen, C. Y. (2024) · Chemical Science · doi:10.1039/d4sc04107k · Cited by 111 · see citing works

Simulation-based approaches for drug delivery systems: Navigating advancements, opportunities, and challenges

Salahshoori, I., Golriz, M., Nobre, M. A. L., Mahdavi, S., Malekshah, R. E., Javdani-Mallak, A., Jorabchi, M. N., Khonakdar, H. A., Wang, Q., Mohammadi, A. H., et al. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2023.123888 · Cited by 106 · see citing works

THE ROLE OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE: A SYSTEMATIC REVIEW OF APPLICATIONS AND CHALLENGES

Udegbe, F. C., Ebulue, O. R., Ebulue, C. C., & Ekesiobi, C. S. (2024) · International Medical Science Research Journal · doi:10.51594/imsrj.v4i4.1052 · Cited by 103 · see citing works

Molecular Mechanism for the Allosteric Inhibition of the Human Serotonin Transporter by Antidepressant Escitalopram

Xue, W., Fu, T., Deng, S., Yang, F., Yang, H. J., & Zhu, F. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00694 · Cited by 100 · see citing works

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control

Wang, S., Li, W., Wang, Z., Yang, W., Li, E., Xia, X., Yan, F., & Chiu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01917-x · Cited by 117 · see citing works

Recent Scaffold Hopping Applications in Central Nervous System Drug Discovery

Callis, T. B., Garrett, T. R., Montgomery, A. P., Danon, J. J., & Kassiou, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00969 · Cited by 99 · see citing works

Artificial intelligence in neurology: opportunities, challenges, and policy implications

Voigtlaender, S., Pawelczyk, J., Geiger, M., Vaios, E., Karschnia, P., Cudkowicz, M., Dietrich, J., Haraldsen, I., Feigin, V. L., Owolabi, M. O., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12220-8 · Cited by 106 · see citing works

Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach

Pan, Y. F., Lei, X., & Zhang, Y. (2021) · Medicinal Research Reviews · doi:10.1002/med.21847 · Cited by 97 · see citing works

Multi‐Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations

Hossain, M. S., & Hussain, M. H. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70131 · Cited by 94 · see citing works

Artificial Intelligence in Genetics

Vilhekar, R. S., & Rawekar, A. (2024) · Cureus · doi:10.7759/cureus.52035 · Cited by 98 · see citing works

Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade

Wang, L., Song, Y., Wang, H., Zhang, X., Wang, M., He, J., Li, S., Zhang, L., Li, K., & Cao, L. (2023) · Pharmaceuticals · doi:10.3390/ph16020253 · Cited by 86 · see citing works

Recent advances in artificial intelligent strategies for tissue engineering and regenerative medicine

Gharibshahian, M., Torkashvand, M., Bavisi, M., Aldaghi, N., & Alizadeh, A. (2024) · Skin Research and Technology · doi:10.1111/srt.70016 · Cited by 87 · see citing works

Mitochondrial Oxidative Stress in Brain Microvascular Endothelial Cells: Triggering Blood-Brain Barrier Disruption.

Wang, Y., Wu, J., Wang, J.-X., He, L.-X., Lai, H., Zhang, T., Wang, X., & Li, W. (2023) · Mitochondrion (Amsterdam. Print) · doi:10.1016/j.mito.2023.01.007 · Cited by 80 · see citing works

Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery

Pasrija, P., Jha, P. K., Upadhyaya, P., Khan, M. S., & Chopra, M. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220701091339 · Cited by 86 · see citing works

Re-Routing Drugs to Blood Brain Barrier: A Comprehensive Analysis of Machine Learning Approaches With Fingerprint Amalgamation and Data Balancing

Ansari, M. Y., Chandrasekar, V., Singh, A. V., & Dakua, S. P. (2022) · IEEE Access · doi:10.1109/access.2022.3233110 · Cited by 82 · see citing works

Artificial intelligence in microbial natural product drug discovery: current and emerging role

Sahayasheela, V. J., Lankadasari, M. B., Dan, V. M., Dastager, S. G., Pandian, G. N., & Sugiyama, H. (2022) · Natural Product Reports · doi:10.1039/d2np00035k · Cited by 83 · see citing works

AI and ML-based risk assessment of chemicals: predicting carcinogenic risk from chemical-induced genomic instability

Singh, A. V., Bhardwaj, P., Laux, P., Pradeep, P., Busse, M., Luch, A., Hirose, A., Osgood, C. J., & Stacey, M. W. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1461587 · Cited by 78 · see citing works

The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges

Chakraborty, C., Bhattacharya, M., Lee, S., Wen, Z., & Lo, Y.-H. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102295 · Cited by 79 · see citing works

The Potential Applications of Artificial Intelligence in Drug Discovery and Development

Farghali, H., Kutinová Canová, N., & Arora, M. (2021) · Physiological Research · doi:10.33549/physiolres.934765 · Cited by 72 · see citing works

A critical review of machine learning algorithms in maritime, offshore, and oil & gas corrosion research: A comprehensive analysis of ANN and RF models

Imran, M. M. H., Jamaludin, S., & Ayob, A. F. M. (2024) · Ocean Engineering · doi:10.1016/j.oceaneng.2024.116796 · Cited by 75 · see citing works

Therapeutic peptide development revolutionized: Harnessing the power of artificial intelligence for drug discovery

Hashemi, S., Vosough, P., Taghizadeh, S., & Savardashtaki, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40265 · Cited by 71 · see citing works

The Role of Artificial Intelligence in Identifying Depression and Anxiety: A Comprehensive Literature Review

Zafar, F., Alam, L. F., Vivas, R. R., Wang, J., Whei, S. J., Mehmood, S., Sadeghzadegan, A., Lakkimsetti, M., & Nazir, Z. (2024) · Cureus · doi:10.7759/cureus.56472 · Cited by 74 · see citing works

Therapeutic targeting of senescent cells in the CNS

Rießland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 74 · see citing works

Clinlabomics: leveraging clinical laboratory data by data mining strategies

Wen, X., Leng, P., Wang, J., Yang, G., Zu, R., Jia, X., Zhang, K., Mengesha, B. A., Huang, J. H., Wang, D., et al. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04926-1 · Cited by 63 · see citing works

Artificial intelligence in drug discovery and development: transforming challenges into opportunities

Kant, S., Deepika, & Roy, S. (2025) · Discover Pharmaceutical Sciences · doi:10.1007/s44395-025-00007-3 · Cited by 78 · see citing works

The Role of Machine Learning in AR/VR-Based Cognitive Therapies: A Systematic Review for Mental Health Disorders

Halkiopoulos, C., & Gkintoni, E. (2025) · Electronics · doi:10.3390/electronics14061110 · Cited by 60 · see citing works

Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease

Cheng, F., Wang, F., Tang, J., Zhou, Y., Fu, Z., Zhang, P., Haines, J. L., Leverenz, J. B., Gan, L., Hu, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101379 · Cited by 63 · see citing works

Machine learning in TCM with natural products and molecules: current status and future perspectives

Ma, S., Liu, J., Li, W., Liu, Y., Hui, X., Qu, P., Jiang, Z., Li, J., & Wang, J. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00741-9 · Cited by 59 · see citing works

Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors

Shiammala, P. N., Duraimutharasan, N. K. B., Vaseeharan, B., Alothaim, A. S., Al‐Malki, E. S., Snekaa, B., Safi, S. Z., Singh, S. K., Velmurugan, D., & Selvaraj, C. (2023) · Methods · doi:10.1016/j.ymeth.2023.09.010 · Cited by 57 · see citing works

Role of artificial intelligence in early diagnosis and treatment of infectious diseases

Srivastava, V., Kumar, R., Wani, M. Y., Robinson, K. M., & Ahmad, A. (2024) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2024.2425712 · Cited by 61 · see citing works

AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal Tropism

Sela, M., Chen, G., Kadosh, H., Kagan, T., Nicola, R., Turutov, S., Richtman, Y., Zhige, L., Albalak, M. R., Kagan, S., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c15013 · Cited by 57 · see citing works

Artificial intelligence-guided discovery of anticancer lead compounds from plants and associated microorganisms

Li, G., Lin, P., Wang, K., Gu, C.-C., & Kusari, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.10.002 · Cited by 55 · see citing works

Artificial intelligence (AI) in drug design and discovery: A comprehensive review

Bhat, A. R., & Ahmed, S. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100049 · Cited by 62 · see citing works

Artificial intelligence used to diagnose osteoporosis from risk factors in clinical data and proposing sports protocols

Fasihi, L., Tartibian, B., Eslami, R., & Fasihi, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-23184-y · Cited by 53 · see citing works

Success stories of AI in drug discovery - where do things stand?

Mak, K.-K., Balijepalli, M. K., & Pichika, M. R. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.1985108 · Cited by 51 · see citing works

The Heart of Transformation: Exploring Artificial Intelligence in Cardiovascular Disease

Chowdhury, M. A., Rizk, R., Chiu, C., Zhang, J., Scholl, J. L., Bosch, T. J., Singh, A. P., Baugh, L. A., McGough, J. S., Santosh, K., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13020427 · Cited by 57 · see citing works

Advanced AI and ML frameworks for transforming drug discovery and optimization: With innovative insights in polypharmacology, drug repurposing, combination therapy and nanomedicine

Ambreen, S., Umar, M., Noor, A., Jain, H., & Ali, R. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117164 · Cited by 50 · see citing works

Artificial intelligence for small molecule anticancer drug discovery

Duo, L., Liu, Y., Ren, J., Tang, B., & Hirst, J. D. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2367014 · Cited by 46 · see citing works

Machine Learning for Multi-Target Drug Discovery: Challenges and Opportunities in Systems Pharmacology

Bi, X., Wang, Y., Wang, J., & Liu, C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091186 · Cited by 46 · see citing works

A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences

Kandhare, P., Kurlekar, M., Deshpande, T., & Pawar, A. (2025) · Drugs and Drug Candidates · doi:10.3390/ddc4010009 · Cited by 56 · see citing works

Explicating the transformative role of artificial intelligence in designing targeted nanomedicine

Akhtar, M., Nehal, N., Gull, A., Parveen, R., Khan, S. I., Khan, S. M., & Ali, J. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2502022 · Cited by 45 · see citing works

Brain-on-a-chip: An emerging platform for studying the nanotechnology-biology interface for neurodegenerative disorders

Rodrigues, R. O., Shin, S.-R., & Bañobre-López, M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02720-0 · Cited by 44 · see citing works

From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes

Dermawan, D., & Alotaiq, N. (2025) · Pharmaceuticals · doi:10.3390/ph18070981 · Cited by 54 · see citing works

A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases

Vicidomini, C., Fontanella, F., D’Alessandro, T., & Roviello, G. N. (2024) · Biomolecules · doi:10.3390/biom14101330 · Cited by 43 · see citing works

Impact of Artificial Intelligence on Drug Development and Delivery

Aundhia, C. J., Parmar, G. R., Talele, C., Shah, N., & Talele, D. R. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266324522240725053634 · Cited by 43 · see citing works

From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care

Tanaka, M. (2025) · Biomedicines · doi:10.3390/biomedicines13010167 · Cited by 42 · see citing works

Artificial intelligence for dementia research methods optimization

Bucholc, M., James, C. R., Khleifat, A. A., Badhwar, A., Clarke, N., Dehsarvi, A., Madan, C. R., Marzi, S. J., Shand, C., Schilder, B. M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13441 · Cited by 42 · see citing works

Artificial intelligence in the clinical laboratory

Hou, H., Zhang, R., & Li, J. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119724 · Cited by 50 · see citing works

Promises of natural products as clinical applications for cancer

Deng, R., Zong, G., Wang, X., Yue, B.-J., Cheng, P., Tao, R., Li, X., Wei, Z., & Lu, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189241 · Cited by 40 · see citing works

Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs

Dorahy, G., Chen, Z., & Balle, T. (2023) · Molecules · doi:10.3390/molecules28031324 · Cited by 41 · see citing works

The diagnostic, therapeutic, and ethical impact of artificial intelligence in modern medicine

Katwaroo, A. R., Adesh, V. S., Lowtan, A., & Umakanthan, S. (2023) · Postgraduate Medical Journal · doi:10.1093/postmj/qgad135 · Cited by 40 · see citing works

Experimental and Computational Methods to Assess Central Nervous System Penetration of Small Molecules

Gupta, M., Feng, J., & Bhisetti, G. (2024) · Molecules · doi:10.3390/molecules29061264 · Cited by 38 · see citing works

Sequential Properties Representation Scheme for Recurrent Neural Network-Based Prediction of Therapeutic Peptides

Otović, E., Njirjak, M., Kalafatović, D., & Mauša, G. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00526 · Cited by 37 · see citing works

A systematic literature review for the prediction of anticancer drug response using various machine‐learning and deep‐learning techniques

Singh, D. P., & Kaushik, B. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14164 · Cited by 42 · see citing works

Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing

Malla, R. R., Sathiyapriya, V., Makena, S., Kapoor, S. S., Verma, D., Raju, A. A., Dunna, M., & Muniraj, N. (2024) · Cancers · doi:10.3390/cancers16081463 · Cited by 42 · see citing works

Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?

Lv, Q., Zhou, F., Liu, X., & Zhi, L. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106894 · Cited by 38 · see citing works

Leading artificial intelligence–driven drug discovery platforms: 2025 landscape and global outlook

Dharmasivam, M., Kaya, B., Akinware, A., Azad, M. G., & Richardson, D. R. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100102 · Cited by 42 · see citing works

Identification of benign and malignant thyroid nodules based on dynamic AI ultrasound intelligent auxiliary diagnosis system

Wang, B., Wan, Z., Li, C., Zhang, M., Shi, Y., Miao, X., Jian, Y., Luo, Y., Yao, J., & Tian, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1018321 · Cited by 35 · see citing works

QSPR Analysis of Drugs for Treatment of Schizophrenia Using Topological Indices

Zhang, X., Saif, M. J., Idrees, N., Kanwal, S., Parveen, S., & Saeed, F. (2023) · ACS Omega · doi:10.1021/acsomega.3c05000 · Cited by 35 · see citing works

Machine learning in Alzheimer’s disease drug discovery and target identification

Geng, C., Wang, Z., & Tang, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102172 · Cited by 34 · see citing works

Recent progress in machine learning approaches for predicting carcinogenicity in drug development

Le, N. Q. K., Tran, T.-X., Nguyen, P.-A., Ho, T.-T., & Nguyen, V. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2356162 · Cited by 32 · see citing works

Beyond Dopamine: Novel Therapeutic Pathways for Parkinson's Disease Through Receptor Signaling

Bhushan, R., Goel, F., & Singh, S. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273325667241212041540 · Cited by 33 · see citing works

Relational graph convolutional networks for predicting blood–brain barrier penetration of drug molecules

Ding, Y., Jiang, X., & Kim, Y. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac211 · Cited by 32 · see citing works

Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications

Agu, P. C., & Obulose, C. N. (2024) · Drug Development Research · doi:10.1002/ddr.22159 · Cited by 33 · see citing works

Synergy between machine learning and natural products cheminformatics: Application to the lead discovery of anthraquinone derivatives

Moshawih, S., Goh, H. P., Kifli, N., Idris, A. C., Yassin, H., Kotra, V., Goh, K. W., Liew, K. B., & Ming, L. C. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14062 · Cited by 31 · see citing works

Targeting Death-Associated Protein Kinases for Treatment of Human Diseases: Recent Advances and Future Directions

Zhang, L., Luo, B., Lü, Y., & Chen, Y. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01606 · Cited by 30 · see citing works

A Review on Deep Learning-driven Drug Discovery: Strategies, Tools and Applications

Sumathi, S., Suganya, K., Swathi, K., Sudha, B., Poornima, A., Varghese, C. A., & Aswathy, R. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230412084137 · Cited by 29 · see citing works

Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry

Maharjan, R., Lee, J., Lee, K., Han, H., Kim, K. H., & Jeong, S. H. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00637-8 · Cited by 31 · see citing works

A Computerized Analysis with Machine Learning Techniques for the Diagnosis of Parkinson’s Disease: Past Studies and Future Perspectives

Rana, A., Dumka, A., Singh, R., Panda, M. K., & Priyadarshi, N. (2022) · Diagnostics · doi:10.3390/diagnostics12112708 · Cited by 29 · see citing works

Revolutionizing Medical Practice: The Impact of Artificial Intelligence (AI) on Healthcare

(2024) · Open Access Journal of Applied Science and Technology · doi:10.33140/oajast.02.01.07 · Cited by 29 · see citing works

Versatile nanomaterials for Alzheimer’s disease: Pathogenesis inspired disease-modifying therapy

Xi, Y., Chen, Y., Jin, Y., Han, G., Song, M., Song, T., Shi, Y., Tao, L., Huang, Z., Zhou, J., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.034 · Cited by 27 · see citing works

Anesthetic drug discovery with computer-aided drug design and machine learning

Liu, X., Xue, Z., Luo, M., Ke, B., & Lv, J. (2024) · Anesthesiology and Perioperative Science · doi:10.1007/s44254-023-00047-x · Cited by 27 · see citing works

Application of artificial intelligence in microbial drug discovery: Unlocking new frontiers in biotechnology

Mulat, M., Banicod, R. J. S., Tabassum, N., Javaid, A., Kim, T., Kim, Y., & Khan, F. (2025) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2025.107232 · Cited by 30 · see citing works

In silico drug design strategies for discovering novel tuberculosis therapeutics

Canales, C. S. C., Pavan, A. R., dos Santos, J. L., & Pavan, F. R. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2319042 · Cited by 26 · see citing works

Artificial Intelligence in Mental Health Care: Management Implications, Ethical Challenges, and Policy Considerations

Hoose, S., & Králiková, K. (2024) · Administrative Sciences · doi:10.3390/admsci14090227 · Cited by 26 · see citing works

Traumatic brain injury: Bridging pathophysiological insights and precision treatment strategies

Lu, Y., Jin, J., Zhang, H., Lu, Q., Zhang, Y., Liu, C., Liang, Y., Tian, S., Zhao, Y., & Fan, H. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01398 · Cited by 26 · see citing works

Artificial intelligence in sickle disease

Elsabagh, A. A., Elhadary, M. R., Elsayed, B., Elshoeibi, A. M., Ferih, K., Kaddoura, R., Alkindi, S. S. A., Alshurafa, A., Al‐Rasheed, M., Alzayed, A., et al. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101102 · Cited by 26 · see citing works

A review on the use of machine learning techniques in monkeypox disease prediction

Rampogu, S. D. (2023) · Science in One Health · doi:10.1016/j.soh.2023.100040 · Cited by 26 · see citing works

Advancements in Molecular Property Prediction: A Survey of Single and Multimodal Approaches

Liyaqat, T., Ahmad, T., & Saxena, C. (2025) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-025-10317-5 · Cited by 36 · see citing works

Artificial Intelligence in Toxicology and Pharmacology

Nasnodkar, S. P., Çınar, B., & Ness, S. (2023) · Journal of Engineering Research and Reports · doi:10.9734/jerr/2023/v25i7952 · Cited by 24 · see citing works

Neuroinflammation and acquired traumatic CNS injury: a mini review

Theus, M. H. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1334847 · Cited by 25 · see citing works

Integrating AI in fighting advancing Alzheimer: diagnosis, prevention, treatment, monitoring, mechanisms, and clinical trials

Angelucci, F., Ai, A. R., Piendel, L. A., Cerman, J., & Hort, J. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2024.102857 · Cited by 25 · see citing works

Advances in machine learning for optimizing pharmaceutical drug discovery

Ogbonna, U. E., Ofoezie, E. F., Babalola, O. O., Ottu, P. O., Ogbonna, C. A., Olisakwe, S. C., George, E. T., Babarinde, S., Omaba, O. J., Chukwuemeka, C. G., et al. (2025) · Current Proteomics · doi:10.1016/j.curpro.2025.100015 · Cited by 24 · see citing works

Multinomial classification of NLRP3 inhibitory compounds based on large scale machine learning approaches

Ishfaq, M., Shah, S. Z. A., Ahmad, I., & Rahman, Z.-U. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10690-y · Cited by 23 · see citing works

A mini-review: recent advancements in temporal interference stimulation in modulating brain function and behavior

Zhu, Z., & Yin, L. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1266753 · Cited by 23 · see citing works

Permeability Benchmarking: Guidelines for Comparing in Silico, in Vitro, and in Vivo Measurements

Jorgensen, C., Linville, R. M., Galea, I., Lambden, E., Vögele, M., Chen, C. H., Troendle, E. P., Ruggiu, F., Ulmschneider, M. B., Schiøtt, B., et al. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01815 · Cited by 22 · see citing works

Brain organoid-on-a-chip: A next-generation human brain avatar for recapitulating human brain physiology and pathology

Song, J., Bang, S., Choi, N., & Kim, H. N. (2022) · Biomicrofluidics · doi:10.1063/5.0121476 · Cited by 23 · see citing works

Application of Computational Intelligence Through the Lens of CNS Drug Discovery: A Study of AI-Driven Predictive Models

Adhikary, S., Sasmal, D., Mukherjee, G., Banerjee, K., & Mallik, B. B. (2025) · Apple Academic Press eBooks · doi:10.1201/9781998511013-15

Advancement of Artificial Intelligence and Machine Learning in Drug Discovery for the Central Nervous System Diseases

Malviya, R., Sharma, R., Sridhar, S. B., & Kumar, S. (2026) · Apple Academic Press eBooks · doi:10.1201/9781779640819-9

Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system

Gautam, V., Gaurav, A., Masand, N., Lee, V. S., & Patil, V. M. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10489-3 · Cited by 39 · see citing works

Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents

Kashyap, K., & Siddiqi, M. I. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10274-8 · Cited by 24 · see citing works

Applications of artificial intelligence in drug discovery for neurological diseases

Ekins, S., & Lane, T. R. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00624 · Cited by 12 · see citing works